Neoadjuvant therapy group:None
Sponsors
Peking University School and Hospital of Stomatology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences, Fifth Affiliated Hospital, Sun Yat-Sen University, Zhongshan People’s Hospital(Affiliated Zhongshan Hospital of Sun Yat-sen University), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Conditions
Esophageal cancerHepatocellular carcinomaOral cancerThere are no obvious symptoms or mild in early stage of esophageal carcinoma. The typical symptom is progressive dysphagia.esophageal cancerhepatocellular carcinoma
Early Phase 1
Unknown Phase
Study on the effects and mechanisms of neoadjuvant therapy on rocuronium induced neuromuscular blockade in esophageal cancer radical surgery
Active, not recruitingChiCTR2400087065
Start: 2024-08-01Updated: 2024-07-22
The Safety and Efficacy of Single-port Inflatable Mediastinoscopy Combined with Laparoscopic Radical Esophagectomy after Neoadjuvant Therapy
Active, not recruitingChiCTR2400093263
Start: 2023-12-12Updated: 2024-12-09
Study on the consistency of clinical efficacy of PTC in vitro drug sensitivity technology for combined immunotherapy for oral cancer
RecruitingChiCTR2500099064
Start: 2025-05-19Updated: 2026-03-02
Clinical efficacy study of neoadjuvant therapy based on hepatic artery infusion chemotherapy for CNLC stage ?b-?b liver cancer
Active, not recruitingChiCTR2500107132
Start: 2024-05-01Updated: 2025-08-18
Comparison of Prognosis and Safety between Neoadjuvant Combined Surgery and Direct Surgery for Resectable HCC Patients in CNLC Stages ?b-?a, and Stratified Analysis of Neoadjuvant Strategies
Active, not recruitingChiCTR2600119979
Start: 2026-03-07Updated: 2026-03-09
Effect and Mechanism of Neoadjuvant Therapy on Residual Neuromuscular Relaxation following Deep Neuromuscular Blockade
Active, not recruitingChiCTR2600124437
Start: 2026-06-01Updated: 2026-05-18